Report Feature
Acute Ocular Pain Trends and Forecast
The future of the global acute ocular pain market looks promising with opportunities in the hospital, homecare, and ophthalmic clinic markets. The global acute ocular pain market is expected to grow with a CAGR of 9.3% from 2024 to 2030. The major drivers for this market are rising elderly population leading to an increased occurrence of ocular conditions, increased research and development activities, and growing need for advanced diagnostic tools and techniques to improve eye screening procedures.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Acute Ocular Pain by Segment
The study includes a forecast for the global acute ocular pain by drug, medical condition, route of administration, end use, and region.Acute Ocular Pain Market by Drug [Shipment Analysis by Value from 2018 to 2030]:
• Topical NSAID
• Topical Cycloplegic Agents
• Oral Analgesics
• Corticosteroids
• Immunomodulators
Acute Ocular Pain Market by Medical Condition [Shipment Analysis by Value from 2018 to 2030]:
• Corneal Abrasion
• Glaucoma
• Conjunctivitis
• Iritis
• Others
Acute Ocular Pain Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Topical
• Periocular
• Intraocular
• Oral
• Others
Acute Ocular Pain Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Homecare
• Ophthalmic Clinics
• Others
Acute Ocular Pain Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Acute Ocular Pain Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute ocular pain companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute ocular pain companies profiled in this report include-• Alcon Vision
• Bausch + Lomb
• Sun Pharmaceutical Industries
• AbbVie
• Ocular Therapeutix
• KALA BIO
• Formosa Pharmaceuticals
• Vyluma
• Sylentis
• Aldeyra Therapeutics
Acute Ocular Pain Market Insights
Lucintel forecasts that corneal abrasion is expected to witness the highest growth over the forecast period. Within this market, hospital is expected to witness the highest growth due to growing elderly population worldwide and the increasing quantity of hospitals. APAC is expected to witness highest growth over the forecast period due to rapidly growing population.Features of the Global Acute Ocular Pain Market
Market Size Estimates: Acute ocular pain market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Acute ocular pain market size by drug, medical condition, route of administration, end use, and region in terms of value ($B). Regional Analysis: Acute ocular pain market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different drug, medical condition, route of administration, end use, and regions for the acute ocular pain market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute ocular pain market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.FAQ
Q1. What is the growth forecast for acute ocular pain market? Answer: The global acute ocular pain market is expected to grow with a CAGR of 9.3% from 2024 to 2030. Q2. What are the major drivers influencing the growth of the acute ocular pain market? Answer: The major drivers for this market are rising elderly population leading to an increased occurrence of ocular conditions, increased research and development activities, and growing need for advanced diagnostic tools and techniques to improve eye screening procedures. Q3. What are the major segments for acute ocular pain market? Answer: The future of the global acute ocular pain market looks promising with opportunities in the hospital, homecare, and ophthalmic clinic markets. Q4. Who are the key acute ocular pain market companies? Answer: Some of the key acute ocular pain companies are as follows:• Alcon Vision
• Bausch + Lomb
• Sun Pharmaceutical Industries
• AbbVie
• Ocular Therapeutix
• KALA BIO
• Formosa Pharmaceuticals
• Vyluma
• Sylentis
• Aldeyra Therapeutics Q5. Which acute ocular pain market segment will be the largest in future? Answer: Lucintel forecasts that corneal abrasion is expected to witness the highest growth over the forecast period. Q6. In acute ocular pain market, which region is expected to be the largest in next 5 years? Answer: APAC is expected to witness highest growth over the forecast period due to rapidly growing population. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.
Table of Contents
1. Executive Summary
6.2 Emerging Trends in the Global Acute Ocular Pain Market
6.1.1 Growth Opportunities for the Global Acute Ocular Pain Market by Drug
6.1.2 Growth Opportunities for the Global Acute Ocular Pain Market by Medical Condition
6.1.3 Growth Opportunities for the Global Acute Ocular Pain Market by Route of Administration
6.1.4 Growth Opportunities for the Global Acute Ocular Pain Market by End Use
6.1.5 Growth Opportunities for the Global Acute Ocular Pain Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the acute ocular pain market by drug (topical NSAIDs, topical cycloplegic agents, oral analgesics, corticosteroids, and immunomodulators), medical condition (corneal abrasion, glaucoma, conjunctivitis, iritis, and others), route of administration (topical, periocular, intraocular, oral, and others), end use (hospitals, homecare, ophthalmic clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Acute Ocular Pain Market, Acute Ocular Pain Market Size, Acute Ocular Pain Market Growth, Acute Ocular Pain Market Analysis, Acute Ocular Pain Market Report, Acute Ocular Pain Market Share, Acute Ocular Pain Market Trends, Acute Ocular Pain Market Forecast, Acute Ocular Pain Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
